You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Anti-thrombin III Testing Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application

Antithrombin (AT, Antithrombin III, ATIII) is a small glycoprotein produced by the liver that inactivates several enzymes of the coagulation system.
α-Antithrombin is the dominant form of antithrombin found in blood plasma and has an oligosaccharide occupying each of its four glycosylation sites. A single glycosylation site remains consistently un-occupied in the minor form of antithrombin, β-antithrombin.
Antithrombin activity is increased by anticoagulant heparin, which enhances the binding of antithrombin to factor II and factor X.
Antithrombin is a serpin (serine protease inhibitor) similar in structure to other plasma protease inhibitors like alpha 1-antichymotrypsin, alpha 2-antiplasmin and Heparin cofactor II.

Market Analysis and Insights: Global Anti-thrombin III Testing Market
The research report studies the Anti-thrombin III Testing market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Anti-thrombin III Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Anti-thrombin III Testing Scope and Segment
The global Anti-thrombin III Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-thrombin III Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Diagnosis of antithrombin deficiency
Activity assays
Immunological assays
by Application, this report covers the following segments
Hospital
Research institute
Clinic
Other
Global Anti-thrombin III Testing market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Anti-thrombin III Testing key players in this market include:
Abbott Laboratories
Danaher Corp.
F. Hoffmann-La Roche Ltd.
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.

1 Market Overview of Anti-thrombin III Testing
1.1 Anti-thrombin III Testing Market Overview
1.1.1 Anti-thrombin III Testing Product Scope
1.1.2 Market Status and Outlook
1.2 Global Anti-thrombin III Testing Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Anti-thrombin III Testing Market Size by Region (2015-2026)
1.4 Global Anti-thrombin III Testing Historic Market Size by Region (2015-2020)
1.5 Global Anti-thrombin III Testing Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Anti-thrombin III Testing Market Size YoY Growth (2015-2026)
1.6.1 North America Anti-thrombin III Testing Market Size YoY Growth (2015-2026)
1.6.2 Europe Anti-thrombin III Testing Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Anti-thrombin III Testing Market Size YoY Growth (2015-2026)
1.6.4 Latin America Anti-thrombin III Testing Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Anti-thrombin III Testing Market Size YoY Growth (2015-2026)

2 Anti-thrombin III Testing Market Overview by Type
2.1 Global Anti-thrombin III Testing Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Anti-thrombin III Testing Historic Market Size by Type (2015-2020)
2.3 Global Anti-thrombin III Testing Forecasted Market Size by Type (2021-2026)
2.4 Diagnosis of antithrombin deficiency
2.5 Activity assays
2.6 Immunological assays

3 Anti-thrombin III Testing Market Overview by Application
3.1 Global Anti-thrombin III Testing Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Anti-thrombin III Testing Historic Market Size by Application (2015-2020)
3.3 Global Anti-thrombin III Testing Forecasted Market Size by Application (2021-2026)
3.4 Hospital
3.5 Research institute
3.6 Clinic
3.7 Other

4 Global Anti-thrombin III Testing Competition Analysis by Players
4.1 Global Anti-thrombin III Testing Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-thrombin III Testing as of 2019)
4.3 Date of Key Manufacturers Enter into Anti-thrombin III Testing Market
4.4 Global Top Players Anti-thrombin III Testing Headquarters and Area Served
4.5 Key Players Anti-thrombin III Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Anti-thrombin III Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Anti-thrombin III Testing Products, Services and Solutions
5.1.4 Abbott Laboratories Anti-thrombin III Testing Revenue (US$ Million) & (2015-2020)
5.1.5 Abbott Laboratories Recent Developments
5.2 Danaher Corp.
5.2.1 Danaher Corp. Profile
5.2.2 Danaher Corp. Main Business
5.2.3 Danaher Corp. Anti-thrombin III Testing Products, Services and Solutions
5.2.4 Danaher Corp. Anti-thrombin III Testing Revenue (US$ Million) & (2015-2020)
5.2.5 Danaher Corp. Recent Developments
5.3 F. Hoffmann-La Roche Ltd.
5.5.1 F. Hoffmann-La Roche Ltd. Profile
5.3.2 F. Hoffmann-La Roche Ltd. Main Business
5.3.3 F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Products, Services and Solutions
5.3.4 F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Revenue (US$ Million) & (2015-2020)
5.3.5 Siemens Healthcare GmbH Recent Developments
5.4 Siemens Healthcare GmbH
5.4.1 Siemens Healthcare GmbH Profile
5.4.2 Siemens Healthcare GmbH Main Business
5.4.3 Siemens Healthcare GmbH Anti-thrombin III Testing Products, Services and Solutions
5.4.4 Siemens Healthcare GmbH Anti-thrombin III Testing Revenue (US$ Million) & (2015-2020)
5.4.5 Siemens Healthcare GmbH Recent Developments
5.5 Thermo Fisher Scientific Inc.
5.5.1 Thermo Fisher Scientific Inc. Profile
5.5.2 Thermo Fisher Scientific Inc. Main Business
5.5.3 Thermo Fisher Scientific Inc. Anti-thrombin III Testing Products, Services and Solutions
5.5.4 Thermo Fisher Scientific Inc. Anti-thrombin III Testing Revenue (US$ Million) & (2015-2020)
5.5.5 Thermo Fisher Scientific Inc. Recent Developments
...

6 North America
6.1 North America Anti-thrombin III Testing Market Size by Country
6.2 United States
6.3 Canada

7 Europe
7.1 Europe Anti-thrombin III Testing Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe

8 Asia-Pacific
8.1 Asia-Pacific Anti-thrombin III Testing Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific

9 Latin America
9.1 Latin America Anti-thrombin III Testing Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America

10 Middle East & Africa
10.1 Middle East & Africa Anti-thrombin III Testing Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa

11 Anti-thrombin III Testing Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
  • FORMAT: PDF
  • PUBLISHED DATE: Nov, 2020
  • NO OF PAGES: 125